Anavex Life Sciences has released promising results from its latest clinical study on ANAVEX2-73, also known as blarcamesine, aimed at treating Parkinson’s Disease Dementia (PDD).
Category: Health
Anavex, a prominent player in the biopharmaceutical industry, recently announced significant findings from its ANAVEX2-73-AD-004 Phase IIb/III trial. This development marks a pivotal moment in
Edgard Corona, the founder of Smart Fit, is not just a fitness entrepreneur—he is a pioneer in shaping the future of wellness in Latin America.